May 16, 2025, 12:00 AM
May 16, 2025, 12:00 AM

Boeing poised for recovery as United Health struggles

Highlights
  • Boeing's stock has fallen by 78.6% since 2019 but shows signs of a potential recovery.
  • Relative strength for Boeing bottomed in mid-November, suggesting a favorable six-month relative strength base.
  • Analysts foresee Boeing's share price could rebound to $230 in the short term and $270 longer-term.
Story

In the United States, Boeing has been experiencing significant challenges since 2019, marked by a continuous decline after a decade-long bull market. The company's stock has plummeted by 78.6% from its previous high, reflecting a series of negative developments that have plagued its operations and investor confidence. However, recent analyses indicate that the company might be approaching a longer-term low, with signs of a potential recovery appearing as relative strength began to stabilize in mid-November of the previous year. Analysts suggest that a crucial six-month relative strength base has formed, which is vital for any sustainable upward movement in its stock price. Boeing's chart patterns exhibit higher momentum lows over both weekly and monthly periods. A significant downtrend line from the peak achieved in 2009 has reportedly been broken, suggesting that a positive rally could be forthcoming. Predictions indicate that Boeing’s share price could reach $230 in the short term, with a longer-term target of $270 if the upward trend continues. On the other hand, United Health has been facing severe pressure, dragging down the Dow Jones Industrial Average (DJIA) significantly. Its stock fell from $599 on April 11 to $308 on May 11, demonstrating a concerning downward trajectory. Since 2022, the relative strength of United Health has also been declining, with no signs of recovery in the near future. Historical data shows that May typically serves as a strong month for the company, as higher prices in May have often correlated with increased prices in subsequent months 60% to 70% of the time over the last four decades. However, United Health did not manage to capitalize on this trend in the current year, closing lower in May. The stock is now expected to reach a low point by late September, potentially falling to $250, which would be a significant retracement consistent with patterns observed over the last 16 years. The prediction around United Health's price highlights ongoing market pressures that could negatively impact the DJIA overall. The interplay of Boeing's recovery and United Health's struggles will likely shape market sentiments in the coming months as investors navigate these contrasting scenarios. This situation presents key insights into stock market dynamics and highlights the need for investors to remain vigilant about the underlying metrics driving these companies' performance in a volatile market landscape.

Opinions

You've reached the end